Prevalence of endogenous normal thyroid function 3 years after hemithyroidectomy for differentiated thyroid cancer
European Thyroid Journal · 2025
DOI: 10.1530/etj-24-0282 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Thyroid Journal, 2025. Verfasst von Tina Toft Kristensen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology Head and Neck Surgery and Audiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroidectomy, Thyroid Gland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To investigate the prevalence of endogenous normal thyroid function 3 years after hemithyroidectomy for low-risk differentiated thyroid cancer if a postoperative thyroid-stimulating hormone increase up to 4 mIU/L is accepted.
Method
A retrospective review of a total of 162 Eastern Danish patients was conducted. Patients were initially followed up without levothyroxine treatment after hemithyroidectomy for differentiated thyroid cancer if thyroid-stimulating hormone was below 4 mIU/L, in accordance with the Danish treatment guideline. Patients’ hospital charts were reviewed, and data on the initiation of levothyroxine treatment, pre- and postoperative thyroid-stimulating hormone, recurrence, and remnant lobe nodularity were collected.
Results
A total of 143/162 (88%) did not take levothyroxine before hemithyroidectomy, with a median (interquartile range) age of 53 (43–65) years; 80% were women. During follow-up, the prevalence of endogenous normal thyroid function gradually decreased to 80, 69, and 66% after 1, 2, and 3 years. Concomitantly, hypothyroidism developed with thyroid-stimulating hormone >4.0 mIU/L in 20, 31, and 34% of patients, who were replaced with levothyroxine. In patients not on levothyroxine, TSH was significantly increased within the normal range 1, 2, and 3 years after hemithyroidectomy for DTC ( P < 0.0001). 4/143 (3%) had completion thyroidectomies due to growth of preexisting nodules; no patient had a recurrence.
Conclusion
One-third of differentiated thyroid cancer patients require levothyroxine treatment 3 years after hemithyroidectomy if postoperative thyroid-stimulating hormone levels up to 4 mIU/L are accepted. Avoidance of levothyroxine treatment happens at the expense of a significant increase in thyroid-stimulating hormone levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology Head and Neck Surgery and Audiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Section of General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
- Department of Oncology, Herlev Hospital, Herlev, Denmark.
- University of Copenhagen, Copenhagen, Denmark.
- Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, USA.
ORCID-Profile: Tina Toft Kristensen
Zitieren
APA
Toft Kristensen, T., Plaschke, C. C., Fog Lomholt, A., Holst Hahn, C., Wessel, I., Toft Kristensen, M. A., Bentzen, J., & Ellervik, C. (2025). Prevalence of endogenous normal thyroid function 3 years after hemithyroidectomy for differentiated thyroid cancer. European Thyroid Journal. https://doi.org/10.1530/etj-24-0282
Vancouver
Toft Kristensen T, Plaschke CC, Fog Lomholt A, Holst Hahn C, Wessel I, Toft Kristensen MA, et al. Prevalence of endogenous normal thyroid function 3 years after hemithyroidectomy for differentiated thyroid cancer. European Thyroid Journal. 2025. doi:10.1530/etj-24-0282
BibTeX
@article{ToftKristensen2025,
author = {Toft Kristensen, Tina and Plaschke, Christina Caroline and Fog Lomholt, Anne and Holst Hahn, Christoffer and Wessel, Irene and Toft Kristensen, Mads Aage and Bentzen, Jens and Ellervik, Christina},
title = {Prevalence of endogenous normal thyroid function 3 years after hemithyroidectomy for differentiated thyroid cancer},
journal = {European Thyroid Journal},
year = {2025},
doi = {10.1530/etj-24-0282}
}
EUVIMED